Cargando…
Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey
The gut microbiota play a pivotal role in human health. Dysbiosis, alterations in microbiota composition and function, is associated with gastrointestinal disorders, including inflammatory bowel disease (IBD). This international survey aimed to assess physicians’ experiences, perceptions, and practi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672996/ https://www.ncbi.nlm.nih.gov/pubmed/38004817 http://dx.doi.org/10.3390/microorganisms11112806 |
_version_ | 1785149570392522752 |
---|---|
author | Parigi, Tommaso Lorenzo Vieujean, Sophie Paridaens, Kristine Dalgaard, Kira Peyrin-Biroulet, Laurent Danese, Silvio |
author_facet | Parigi, Tommaso Lorenzo Vieujean, Sophie Paridaens, Kristine Dalgaard, Kira Peyrin-Biroulet, Laurent Danese, Silvio |
author_sort | Parigi, Tommaso Lorenzo |
collection | PubMed |
description | The gut microbiota play a pivotal role in human health. Dysbiosis, alterations in microbiota composition and function, is associated with gastrointestinal disorders, including inflammatory bowel disease (IBD). This international survey aimed to assess physicians’ experiences, perceptions, and practices related to microbiome modulation for gastrointestinal conditions, with a focus on IBD. Results from 142 healthcare professionals, predominantly gastroenterologists, confirmed a consensus on the relevance of the gut microbiota in IBD pathogenesis. However, the utilization of microbial composition analysis and probiotics in clinical practice was limited, primarily due to the lack of standardized guidelines and supporting evidence. Physicians held conflicting views on antibiotics, recognizing their potential for inducing remission but also causing flares in IBD. Respondents also had varying opinions on the efficacy of fecal microbiota transplantation (FMT) for different gastrointestinal conditions, with higher confidence in FMT effectiveness for irritable bowel syndrome with diarrhea, pouchitis, and ulcerative colitis. Concerns on FMT included uncertainty about effect duration, administration intervals, and conflicting evidence. Donor selection was believed to be a crucial factor in FMT outcomes. This survey highlights the need for further research and evidence-based guidelines to optimize the use of microbiome-based therapies in clinical practice. As our understanding of the gut microbiome continues to evolve, these insights will contribute to more informed and personalized approaches to managing gastrointestinal disorders. |
format | Online Article Text |
id | pubmed-10672996 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106729962023-11-19 Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey Parigi, Tommaso Lorenzo Vieujean, Sophie Paridaens, Kristine Dalgaard, Kira Peyrin-Biroulet, Laurent Danese, Silvio Microorganisms Article The gut microbiota play a pivotal role in human health. Dysbiosis, alterations in microbiota composition and function, is associated with gastrointestinal disorders, including inflammatory bowel disease (IBD). This international survey aimed to assess physicians’ experiences, perceptions, and practices related to microbiome modulation for gastrointestinal conditions, with a focus on IBD. Results from 142 healthcare professionals, predominantly gastroenterologists, confirmed a consensus on the relevance of the gut microbiota in IBD pathogenesis. However, the utilization of microbial composition analysis and probiotics in clinical practice was limited, primarily due to the lack of standardized guidelines and supporting evidence. Physicians held conflicting views on antibiotics, recognizing their potential for inducing remission but also causing flares in IBD. Respondents also had varying opinions on the efficacy of fecal microbiota transplantation (FMT) for different gastrointestinal conditions, with higher confidence in FMT effectiveness for irritable bowel syndrome with diarrhea, pouchitis, and ulcerative colitis. Concerns on FMT included uncertainty about effect duration, administration intervals, and conflicting evidence. Donor selection was believed to be a crucial factor in FMT outcomes. This survey highlights the need for further research and evidence-based guidelines to optimize the use of microbiome-based therapies in clinical practice. As our understanding of the gut microbiome continues to evolve, these insights will contribute to more informed and personalized approaches to managing gastrointestinal disorders. MDPI 2023-11-19 /pmc/articles/PMC10672996/ /pubmed/38004817 http://dx.doi.org/10.3390/microorganisms11112806 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Parigi, Tommaso Lorenzo Vieujean, Sophie Paridaens, Kristine Dalgaard, Kira Peyrin-Biroulet, Laurent Danese, Silvio Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey |
title | Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey |
title_full | Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey |
title_fullStr | Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey |
title_full_unstemmed | Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey |
title_short | Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey |
title_sort | efficacy, safety, and concerns on microbiota modulation, antibiotics, probiotics, and fecal microbial transplant for inflammatory bowel disease and other gastrointestinal conditions: results from an international survey |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672996/ https://www.ncbi.nlm.nih.gov/pubmed/38004817 http://dx.doi.org/10.3390/microorganisms11112806 |
work_keys_str_mv | AT parigitommasolorenzo efficacysafetyandconcernsonmicrobiotamodulationantibioticsprobioticsandfecalmicrobialtransplantforinflammatoryboweldiseaseandothergastrointestinalconditionsresultsfromaninternationalsurvey AT vieujeansophie efficacysafetyandconcernsonmicrobiotamodulationantibioticsprobioticsandfecalmicrobialtransplantforinflammatoryboweldiseaseandothergastrointestinalconditionsresultsfromaninternationalsurvey AT paridaenskristine efficacysafetyandconcernsonmicrobiotamodulationantibioticsprobioticsandfecalmicrobialtransplantforinflammatoryboweldiseaseandothergastrointestinalconditionsresultsfromaninternationalsurvey AT dalgaardkira efficacysafetyandconcernsonmicrobiotamodulationantibioticsprobioticsandfecalmicrobialtransplantforinflammatoryboweldiseaseandothergastrointestinalconditionsresultsfromaninternationalsurvey AT peyrinbirouletlaurent efficacysafetyandconcernsonmicrobiotamodulationantibioticsprobioticsandfecalmicrobialtransplantforinflammatoryboweldiseaseandothergastrointestinalconditionsresultsfromaninternationalsurvey AT danesesilvio efficacysafetyandconcernsonmicrobiotamodulationantibioticsprobioticsandfecalmicrobialtransplantforinflammatoryboweldiseaseandothergastrointestinalconditionsresultsfromaninternationalsurvey |